Cite
HARVARD Citation
McInnes, I. et al. (n.d.). 185 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. Rheumatology. p. . [Online].